Journal
CURRENT APPLIED PHYSICS
Volume 9, Issue -, Pages S19-S21Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cap.2008.08.039
Keywords
MRI; T2 contrast agent; USPIO; PCLNP
Funding
- Ministry of Health and Welfare [02-PJ3-PG6-EV10-0001]
- Brain Korea 21 Project
- Ministry of Health and Welfare [02-PJ3-PG6-EV10-0001]
- Brain Korea 21 Project
Ask authors/readers for more resources
A new synthetic method leading to the formation of polycaprolactone (PCL)/iron oxide nanoparticles using polyvinylpyrrolidone (PVP) is described. The unique feature of this method is that the conventional polymerization step can be avoided. A stable colloidal dispersion of the PCL-coated iron oxide nanoparticles (PCLNP) is thus formed in the presence of PVP as a stabilizer. The PCLNP has a mean diameter of 20-50 nm as measured by TEM. Magnetic measurement by SQUID shows that the PCLNP has a strong superparamagnetism to be used as a liver MR T2 agent. (C) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available